FDA Adverse Event Injury Summary report: N

ENDOTAK ENDURANCE

MDR report key: 1870762 · Received October 15, 2010

Report

Report Number
2124215-2010-17107
Event Type
Injury
Date Received
October 15, 2010
Date of Event
August 16, 2010
Report Date
August 23, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
PMA / PMN Number
P910073
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WILL BE RETURNED, HOWEVER THE LEADS WERE DISCARDED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS EVENT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D), DEFIBRILLATION, TRANSVENOUS, AND CORONARY SINUS LEADS WERE EXPLANTED DUE TO A PATIENT INFECTION. NO FURTHER ADVERSE PATIENT EFFECTS WERE REPORTED. A REQUEST WAS MADE FOR PRODUCT RETURN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK ENDURANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0154

Patients

Seq Age Sex Outcome Treatment
1 75 YR Required Intervention N118| 0154| 4469| 1861| 4518| H175